Bayer Korea unveils new treatment for age-related macular degeneration

Published: 2013-07-04 06:56:00
Updated: 2013-07-04 06:56:00
Bayer Korea said Tuesday it has started selling Eylea (aflibercept) injection for the treatment of patients with neovascular age-related macular degeneration.

Eylea is a recombinant fusion protein, consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc por...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.